Skip to main content
Arthur Kim, MD, Infectious Disease, Boston, MA

ArthurYu ShinKimMD

Infectious Disease Boston, MA

Assistant Professor of Medicine, Massachusetts General Hospital

Dr. Kim is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Kim's full profile

Already have an account?

  • Office

    55 Fruit St
    Cox 5
    Boston, MA 02114
    Phone+1 617-726-3906
    Fax+1 617-726-7653

Education & Training

  • Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical School
    Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 2000 - 2003
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 1997 - 2000
  • Harvard Medical School
    Harvard Medical SchoolClass of 1997

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2002 - 2026
  • American Board of Internal Medicine Infectious Disease

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Efficacy of Tocilizumab in Patients Hospitalized with Covid-19  
    Naomi J Serling-Boyd, Ann E Woolley, Manish Sagar, Harry Schrager, David S Huckins, Jorge Fleisher, Rachel S Wallwork, Arthur Y Kim, Pritha Sen, Eric Meyerowitz, Megan..., The New England Journal of Medicine
  • Efficacy of Tocilizumab in Patients Hospitalized with Covid-19  
    Naomi J Serling-Boyd, Ann E Woolley, Manish Sagar, Harry Schrager, Jorge Fleisher, Rachel S Wallwork, Arthur Y Kim, Pritha Sen, Eric Meyerowitz, Megan M Lockwood, Mich..., The New England Journal of Medicine
  • Efficacy of Tocilizumab in Patients Hospitalized with Covid-19  
    Naomi J Serling-Boyd, Ann E Woolley, Manish Sagar, Harry Schrager, Jorge Fleisher, Rachel S Wallwork, Arthur Y Kim, Pritha Sen, Eric Meyerowitz, Megan M Lockwood, Mich..., The New England Journal of Medicine
  • Join now to see all

Authored Content

  • Management of Hepatitis A in 2020-2021July 2020

Press Mentions

  • We Have a Cure for Hepatitis C. Why Are Hundreds of New Englanders Still Dying Every Year?
    We Have a Cure for Hepatitis C. Why Are Hundreds of New Englanders Still Dying Every Year?November 29th, 2022
  • The Monoclonal Antibodies Strike Back: New Data on Their Use in COVID-19
    The Monoclonal Antibodies Strike Back: New Data on Their Use in COVID-19September 14th, 2021
  • 7 Lessons We've Learned from This Pandemic to Remember for the Next One
    7 Lessons We've Learned from This Pandemic to Remember for the Next OneJune 11th, 2021
  • Join now to see all

Grant Support

  • Discovery And Assessment Of Genetic Determinants Of HCV And HIV ControlNational Institute On Drug Abuse2011
  • Acute HCV In The Prison PopulationNational Institute Of Allergy And Infectious Diseases2010–2011
  • Discovery And Assessment Of Genetic Determinants Of HCV And HIV ControlNational Institute Of Allergy And Infectious Diseases2010
  • Acute Hepatitis C Virus Infection In The Prison PopulationNational Institute Of Allergy And Infectious Diseases2007–2009
  • Cell Mediated Immunity To HCV In HIV+ PersonsNational Institute Of Allergy And Infectious Diseases2003–2007
  • Acute HCV Infection In The Prison PopulationNational Institute Of Allergy And Infectious Diseases2005–2006
  • Cell-Mediated Immunity To HCV In HIV+ PersonsNational Institute Of Allergy And Infectious Diseases2004–2006

Professional Memberships